Animal Study Will Evaluate SLS-007 as a Treatment for Parkinson’s Disease
Free-Photos / Pixabay

Animal Study Will Evaluate SLS-007 as a Treatment for Parkinson’s Disease

Researchers at Seelos Therapeutics are planning an animal study to evaluate SLS-007, a treatment for Parkinson's disease. According to an article from Parkinson's News Today, this study is possible after…

Continue Reading Animal Study Will Evaluate SLS-007 as a Treatment for Parkinson’s Disease
Positive Results from Trial of Sotatercept, a Treatment for Pulmonary Arterial Hypertension
qimono / Pixabay

Positive Results from Trial of Sotatercept, a Treatment for Pulmonary Arterial Hypertension

Acceleron Pharma has released the results from Phase 2 of their PULSAR trial, which studied sotatercept as a treatment for pulmonary arterial hypertension. Researchers are very excited by the positive…

Continue Reading Positive Results from Trial of Sotatercept, a Treatment for Pulmonary Arterial Hypertension
First Two Patients Treated with AMT-130 for Huntington’s Disease Trial
DarkoStojanovic / Pixabay

First Two Patients Treated with AMT-130 for Huntington’s Disease Trial

uniQure has recently began their Phase I/II clinical trial of AMT-130, a gene therapy for the treatment of Huntington's disease. Two patients are included so far, with one being given…

Continue Reading First Two Patients Treated with AMT-130 for Huntington’s Disease Trial

Study: Dietary Agent Prevents Neurodegeneration in Parkinson’s Disease

According to Parkinson's News Today, researchers have created a silicon-based antioxidant agent that can be supplemented into the diet to prevent neurodegeneration and issues with coordination and motor skills associated…

Continue Reading Study: Dietary Agent Prevents Neurodegeneration in Parkinson’s Disease
Study: Gene Therapy as a Treatment for Duchenne Muscular Dystrophy
stux / Pixabay

Study: Gene Therapy as a Treatment for Duchenne Muscular Dystrophy

According to Medical Xpress, a new gene therapy has been studied for the treatment of Duchenne muscular dystrophy. This treatment, SRP-9001, has been shown to deliver micro-dystrophin and improve functional…

Continue Reading Study: Gene Therapy as a Treatment for Duchenne Muscular Dystrophy
FDA Approves CRYSVITA for Tumor-Induced Osteomalacia
source: pixabay.com

FDA Approves CRYSVITA for Tumor-Induced Osteomalacia

Ultragenyx Pharmaceutical's therapy, CRYSVITA, has recently been approved by the FDA for the treatment of FGF23-related hypophosphatemia in tumor-induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors. This approval comes after…

Continue Reading FDA Approves CRYSVITA for Tumor-Induced Osteomalacia
Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
mohamed_hassan / Pixabay

Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

According to the ASCO Post, researchers have discovered genomic characteristics of smoldering multiple myeloma that can tell one's risk of progression to multiple myeloma. Dr. Mark Bustoros and his team…

Continue Reading Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

US Veterans with Pulmonary Hypertension Are Not Treated with Exercise Rehabilitation

According to Healio, US veterans affected by pulmonary arterial hypertension are typically not treated with exercise rehabilitation, despite the fact that many medical professionals believe that utilizing exercise rehabilitation in…

Continue Reading US Veterans with Pulmonary Hypertension Are Not Treated with Exercise Rehabilitation
Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients

Acadia Pharmaceuticals recently released the results of their Phase 3 trial of Nuplazid, a treatment for the psychosis that Parkinson's disease patients experience. This medication has been approved since 2016,…

Continue Reading Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
Study: Ultomiris Resolves Complications of aHUS
Photo by Robina Weermeijer on Unsplash

Study: Ultomiris Resolves Complications of aHUS

Ultomiris, a product of Alexion Pharmaceuticals, has recently been studied in a Phase 3 clinical trial. This study was intended to ultomiris' effect on life-threatening complications of atypical hemolytic uremic…

Continue Reading Study: Ultomiris Resolves Complications of aHUS
Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation
source: pixabay.com

Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation

Immune-Onc Therapeutics recently received clearance from the FDA to begin trials of IO-202, a treatment for acute myeloid leukemia (AML). This news comes after the cancer immunotherapy company filed an…

Continue Reading Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation

Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis

The European Commission has recently granted approval to Bristol Myers Squibb (BMS) for their multiple sclerosis (MS) treatment, Zeposia. It has already been approved by the FDA in the US…

Continue Reading Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis
Close Menu